Skip to content

Multifocal Contact Lenses Fitting Methods Comparison

Biofinity Multifocal Contact Lenses Fitting Methods Comparison

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05734846
Enrollment
25
Registered
2023-02-21
Start date
2022-10-11
Completion date
2022-12-01
Last updated
2024-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Brief summary

The purpose of this study was to compare the clinical performance of two fitting approaches for multifocal contact lenses.

Detailed description

This was a prospective, cross-over, double-masked (participants and investigator), randomized order of testing study. It compared two fitting approaches for silicone hydrogel multifocal contact lenses to assess which method achieved greater vision satisfaction and performance.

Interventions

DEVICEControl Lenses (control fitting approach)

Daily wear multifocal lenses for 1 week

DEVICETest Lenses (test fitting approach)

Daily wear multifocal lenses for 1 week

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 40 years old; * Have read and understood the Participant Information Sheet; * Have read, signed and dated the Informed Consent; * Best corrected visual acuity of at least 20/25 in each eye; * Have normal eyes with the exception of the need for visual correction; * Current multifocal contact lens wearer; * Spectacle refraction: Distance: Sphere: -6.00D to + 4.00D Astigmatism: 0.00D to -0.75D Near Addition: Established Presbyopes: +1.50D & +1.75D * Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule.

Exclusion criteria

* Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear; * Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator; * Monocular participants (only one eye with functional vision) or participants fit with only one lens; * Any moderate or severe ocular condition observed during the slit-lamp examination at the enrolment visit; * History of herpetic keratitis, ocular surgery or irregular cornea; * Known pregnancy or lactation during the study period; * Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator's staff, or individuals living in the households of these individuals.

Design outcomes

Primary

MeasureTime frameDescription
Overall Vision SatisfactionOne weekOverall vision satisfaction for each lens was measured on a 0-100 point Visual Analog Scale (VAS), where 0=Extremely Unsatisfied and 100=Extremely Satisfied
Overall Lens PreferenceTwo weeksParticipants selected their preferred lens fitting approach from options - 'Control', 'Test', or 'No Preference'

Secondary

MeasureTime frameDescription
Overall Binocular Visual Acuity IndexOne weekMean binocular visual performance for each lens was measured by timed logMAR charts. Overall binocular logMAR visual acuity index was calculated by taking the mean of distance and near visual acuities
Number of Contact LensesOne weekThis measured the ease of fitting each contact lens. It counted the number of contact lenses (pair), selected as per the fitting guide, used to determine the final contact lens to dispense.

Countries

United Kingdom

Participant flow

Pre-assignment details

Twenty-five participants were screened and subsequently enrolled in the study.

Participants by arm

ArmCount
Overall Study Population
Includes all study participants.
25
Total25

Baseline characteristics

CharacteristicOverall Study Population
Age, Continuous53.6 years
STANDARD_DEVIATION 2.5
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Overall Lens Preference

Participants selected their preferred lens fitting approach from options - 'Control', 'Test', or 'No Preference'

Time frame: Two weeks

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Control LensesOverall Lens PreferenceControl Lenses10 Participants
Control LensesOverall Lens PreferenceTest Lenses11 Participants
Control LensesOverall Lens PreferenceNo Preference4 Participants
Primary

Overall Vision Satisfaction

Overall vision satisfaction for each lens was measured on a 0-100 point Visual Analog Scale (VAS), where 0=Extremely Unsatisfied and 100=Extremely Satisfied

Time frame: One week

ArmMeasureValue (MEAN)Dispersion
Control LensesOverall Vision Satisfaction78.6 score on a scaleStandard Deviation 18.3
Test LensesOverall Vision Satisfaction83.5 score on a scaleStandard Deviation 14.9
Secondary

Number of Contact Lenses

This measured the ease of fitting each contact lens. It counted the number of contact lenses (pair), selected as per the fitting guide, used to determine the final contact lens to dispense.

Time frame: One week

ArmMeasureValue (MEAN)Dispersion
Control LensesNumber of Contact Lenses1 number of contact lenses (pair)Standard Error 0
Test LensesNumber of Contact Lenses1 number of contact lenses (pair)Standard Error 0
Secondary

Overall Binocular Visual Acuity Index

Mean binocular visual performance for each lens was measured by timed logMAR charts. Overall binocular logMAR visual acuity index was calculated by taking the mean of distance and near visual acuities

Time frame: One week

ArmMeasureValue (MEAN)Dispersion
Control LensesOverall Binocular Visual Acuity Index0.12 logMARStandard Deviation 0.04
Test LensesOverall Binocular Visual Acuity Index0.09 logMARStandard Deviation 0.05

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026